The role of antifibrotics in the treatment of rheumatoid arthritis–associated interstitial lung disease

The major pulmonary complication of rheumatoid arthritis (RA) is interstitial lung disease (ILD), which causes significant morbidity and mortality and influences the natural course of disease. Recent advances in the management of arthritis have improved patient outcomes. However, exceptionally high...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Minrui, Matteson, Eric L., Abril, Andy, Distler, Jörg H.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Interstitial Lung Disease in Autoimmune Rheumatic Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852164/
https://www.ncbi.nlm.nih.gov/pubmed/35186127
http://dx.doi.org/10.1177/1759720X221074457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852164/
https://www.ncbi.nlm.nih.gov/pubmed/35186127
http://dx.doi.org/10.1177/1759720X221074457

Ejemplares similares